Optimization and Formulation Design with In-Vitro Evaluation of Fast Disintegrating Tablets Containing Candesartan Solid Dispersions

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 6

Abstract

The aim of this study was to assess the effects of processing parameters on the release of solid dispersion formulation from a fast dissolving tablet dosage form. Graphical and mathematical analysis such as the response surface methodology (RSM) and multiple response optimizations utilizing the polynomial equation were used to search for the optimal formulation and to quantify the effect of each formulation variables. To optimize the influence of superdisintegrant (crospovidone) and subliming agent (camphor) on the prediction of disintegration time (Y1), percentage friability (Y2) and wetting time (Y3), a two factor, three levels (32) full factorial design was used. Results of multiple regression analysis revealed that an optimum concentration of camphor and a higher percentage of crospovidone are required for obtaining rapidly disintegrating tablets. The optimized formulation was subsequently subjected to a short-term accelerated stability study. Processing parameters have shown a profound effect on the release of solid dispersion formulations from its hydrophilic carrier. The observed results of Y1, Y2 and Y3 coincided well with the predictions in the RSM optimization technique, indicating it was quite useful for optimizing pharmaceutical formulation. The release kinetic of drug from fast dissolving tablets followed the first-order release pattern. Experimental values obtained from the optimized formulations were in close to the predicted values, thus confirming the validity of the generated mathematical model. In conclusion, this study demonstrated the potential of statistical experimental design in elucidating the effects of the formulation variables on the rapidly disintegrating tablets containing solid dispersion of a hydrophobic drug.

Authors and Affiliations

Gurunath S*, Baswaraj KN and Patil PA

Keywords

Related Articles

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Moexipril and Hydrochlorothiazide in Bulk and Tablet Dosage Form

A simple, fast, precise reverse phase and isocratic HPLC method was developed for the separation and quantification of Moexipril (MXP) and Hydrochlorothiazide (HCT) in pharmaceutical dosage form. The quantification was c...

Evaluation of the Perspective of Healthcare Professionals on Complementary Medicine and Supplementary Foods in Turkey

The recognition of complementary medicine and its inclusion in treatment processes has shown a significant increase in the last decade worldwide. Employing methods of complementary medicine in preventive and complementar...

To Study the Effect of Swertiamarin in Animal Model of Huntington’s Disease

Objective: The Data suggest that swertiamarin has antioxidant activity and they modulate neurotoxicity induced oxidative impairments in the brain and can be effectively employed as a neuroprotective. The preclinical find...

Investigation of Phytochemical Profile and Combine Synergistic Anti-Diarrheal Potential of Peperomia Pellucida Aerial Part and Cyprus Esculentus Root Extracts

Peperomia pellucida and Cyperus esculentuslocally found plant used for anti-diarrhoeal activity using standard animal model. The aerial parts of Peperomia pellucidaand Cyperus esculentuswere collected from Trikaripur for...

The Influence of Cholinergic System on Rheumatoid Arthritis

Rheumatoid arthritis is one of the most prevalent immune-mediated arthritis and is categorized as a chronic, inflammatory and autoimmune disease, which mainly affects the cartilage, synovial joint, and bone, the causes o...

Download PDF file
  • EP ID EP745874
  • DOI 10.23880/oajpr-16000135
  • Views 1
  • Downloads 0

How To Cite

Gurunath S*, Baswaraj KN and Patil PA (2017). Optimization and Formulation Design with In-Vitro Evaluation of Fast Disintegrating Tablets Containing Candesartan Solid Dispersions. Open Access Journal of Pharmaceutical Research, 1(6), -. https://europub.co.uk/articles/-A-745874